Precision Xtra Blood Glucose & Ketone Monitoring System, UDI: 00093815715023, 00093815988144

FDA Device Recall #Z-1556-2020 — Class II — November 14, 2019

Recall Summary

Recall Number Z-1556-2020
Classification Class II — Moderate risk
Date Initiated November 14, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Abbott Diabetes Care, Inc.
Location Alameda, CA
Product Type Devices
Quantity N/A

Product Description

Precision Xtra Blood Glucose & Ketone Monitoring System, UDI: 00093815715023, 00093815988144

Reason for Recall

Instructions sent in a letter or in instructions for use for disinfecting blood glucose and/or ketone meters were distributed but not cleared by the U.S. FDA, and devices were not cleared for multiple-patient use. Instructions could lead to inappropriate meter disinfection or improper handling of contaminated meters, which may cause infection or exacerbation of an existing infection.

Distribution Pattern

U.S.: KY, NY, TN, MA, IL, SC, VT, FL, CA, NC, MS, NJ, TX, AL, GA, OK, CT, PA, NE, ND, MT, MO, DC, ME, LA, KS, ID, OH, MN, NM, VA, IN

Lot / Code Information

Not associated with specific model/lot numbers.

Other Recalls from Abbott Diabetes Care, Inc.

Recall # Classification Product Date
Z-1020-2026 Class I FreeStyle Libre 3 Sensor REF 72081-01 UDI-DI co... Nov 24, 2025
Z-1023-2026 Class I FreeStyle Libre 3 Plus Sensor REF 72080-01 UDI-... Nov 24, 2025
Z-1021-2026 Class I FreeStyle Libre 3 Plus Sensor REF 78768-01 UDI-... Nov 24, 2025
Z-1022-2026 Class I FreeStyle Libre 3 Plus Sensor REF 78769-01 UDI-... Nov 24, 2025
Z-2692-2024 Class I FreeStyle Libre 3 Sensors, REF: 72081-01, compo... Jul 24, 2024

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.